• A Case of Atypical Familial Mediterranean Fever With Pseudopolyposis-Like Mucosal Changes in the Ileum
• A narrative review on the role of cytokines in the pathogenesis and treatment of familial Mediterranean fever: an emphasis on pediatric cases
• A Pelvic Hernia Through Two Defects in the Pouch of Douglas in a Patient With Peritoneal Xanogranuloma: A Report of a Very Rare Case
• A treatment algorithm for familial Mediterranean fever patients with menstruation-associated attacks
• Acute Myopericarditis as the First Manifestation of Familial Mediterranean Fever: A Case Report
• Acute Parotitis due to Familial Mediterranean Fever: A Case Report
• Altered expression of miR-17 and miR-148b in pediatric familial mediterranean fever patients
• An "On Demand" canakinumab regimen for treating children with Colchicine-Resistant familial Mediterranean fever - A multicentre study
• Associations of <em>MEFV</em> gene variants, IL-33, and sST2 with the risk of Henoch-Schönlein purpura in children
• Autoinflammatory Diseases - A Review
• Autoinflammatory Diseases: A Review
• bDMARD can prevent the progression of AA amyloidosis to end-stage renal disease
• C-reactive protein is more suitable than Serum Amyloid A to monitor crises and attack-free periods in Systemic Auto-Inflammatory Diseases
• Canakinumab treatment real world evidence in 3 monogenic periodic fever syndromes in 2009-2022: an interim analysis using the French JIR cohort database
• Case report: Other autoinflammatory mutations in a patient with atypical familial Mediterranean fever symptoms
• Challenges in diagnosing familial Mediterranean fever: exploring atypical clinical features. Clinical case
• Characteristics of arthritis in patients with familial Mediterranean fever
• Clinical Associations of E148Q Heterozygosity: What to Expect From E148Q?
• Clinical Characteristics and Outcomes of Polyarteritis Nodosa - an International Study
• Clinical Characteristics and Outcomes of Polyarteritis Nodosa: An International Study
• Clostridioides difficile infection as a potential trigger for Familial Mediterranean Fever attacks and fecal transplantation as a rescue
• Coexistence of familial Mediterranean fever and seronegative spondyloarthritis: peculiarities of the course
• Coexistence of steroid-resistant minimal change disease and familial Mediterranean fever: A case report
• Colchicine for the treatment of the spectrum of cardiovascular diseases: current evidence and ongoing perspectives
• Comparison of Clinical and Genetic Characteristics of Familial Mediterranean Fever Patients Among Adult Age Groups
• Comparison of dietary inflammatory index and total antioxidant capacities of familial Mediterranean fever and healthy adolescents
• Could tocilizumab be used in familial Mediterranean Fever? A systematic review
• Dermatological Comorbidities in Patients with Familiar Mediterranean Fever
• Diverticulitis? Pleurisy? No! Familial Mediterranean fever? Yes!
• E148Q variant: a familial Mediterranean fever-causing mutation or a sequence variant?
• Effects of intrauterine device use on attack frequency and severity in woman of reproductive age with familial Mediterranean fever
• Epigenetic insights into Familial Mediterranean Fever: Increased RGS10 expression and histone modifications accompanies inflammation in familial Mediterranean fever disease
• Epigenetic, transcriptional, and functional characterization of myeloid cells in familial Mediterranean fever
• Evaluation of cardiac functions in children with familial Mediterranean fever
• Examination of cardiac functions during acute attack and remission period in children with familial Mediterranean fever
• Exploring S100A8/A9, Neopterin, and MMP3 in Familial Mediterranean Fever
• Factors triggering familial mediterranean fever attacks, do they really exist?
• Familial mediterranean fever
• Familial Mediterranean fever gene variations could trigger VPS16-associated early-onset dystonia and diabetes mellitus: clinical identification of a family with MEFV and VPS16 genetic variation association
• Familial Mediterranean fever in Armenian children with inflammatory bowel disease
• Familial Mediterranean fever in patients with inflammatory bowel diseases: A nationwide study from the epi-IIRN
• Familial Mediterranean Fever Mimicking Metastatic Crohn's Disease
• Familial Mediterranean Fever-Associated Retinal Vasculitis: A Rare Manifestation Successfully Managed with IL-1 Pathway Inhibitors
• Family reflections: familial Mediterranean fever
• Generating Concentration Gradients across Membranes for Molecular Dynamics Simulations of Periodic Systems
• Generation of iPSCs from a Patient with the M694V Mutation in the MEFV Gene Associated with Familial Mediterranean Fever and Their Differentiation into Macrophages
• Health conditions of first-degree relatives of children with familial Mediterranean fever
• Heterozygous Pyrin (MEFV) E148Q allele carriers indicate a reduced glaucoma risk for Turkish population: a prospective clinical analysis
• High frequency of MEFV disease-causing variants in children with very-early-onset inflammatory bowel disease
• How do gene mutation diversity and disease severity scoring affect physical capacity and quality of life in children/adolescents with Familial Mediterranean Fever?
• Identifying high-risk neurological phenotypes in adult-onset classic monogenic autoinflammatory diseases: when should neurologists consider testing?
• IL-1 Inhibitors in the Treatment of Familial Mediterranean Fever: Treatment Indications and Clinical Features in a Large Real-World Cohort
• Impact of multiple MEFV variants of unknown significance on the diagnosis and clinical presentation of familial Mediterranean fever
• Inflammation, Colchicine, and Atherosclerotic Disease: Is Familial Mediterranean Fever an Exception That Proves the Rule?
• Interrupting an IFN-γ-dependent feedback loop in the syndrome of pyogenic arthritis with pyoderma gangrenosum and acne
• Ischemia-modified albumin in rheumatic diseases: A systematic review and meta-analysis
• Late initiation of anakinra can induce complete renal response in renal AA amyloidosis secondary to Familial Mediterranean Fever
• Long-term safety and effectiveness of canakinumab in patients with monogenic autoinflammatory diseases: results from the interim analysis of the RELIANCE registry
• Marshall syndrome
• Molecular analyses of MEFV gene mutation variants in Turkish population
• Optimized Treatment of Interleukin (IL-1)-Mediated Autoinflammatory Diseases: Impact of Disease Activity-Based Treatment Adjustments
• p.(Tyr135His), a new variant associated with familial Mediterranean fever
• Pan-Immune-Inflammation Value Could Be a New Marker to Predict Amyloidosis and Disease Severity in Familial Mediterranean Fever
• Patient Experiences and Challenges in the Management of Autoinflammatory Diseases-Data from the International FMF &amp; AID Global Association Survey
• Perioperative care of the patient with a periodic fever syndrome
• Physical fitness in adolescent patients with familial Mediterranean fever
• Placebo-resistant gut bacteria: Akkermansia muciniphila spp. and Familial Mediterranean fever disease
• Plasminogen activator inhibitor-1 genotype 4G/5G associates with skin involvement in Armenian familial Mediterranean fever patients
• Potential association between M694V homozygous mutation in familial Mediterranean fever and eosinophilic intestinal inflammation: a pediatric case series
• Predicting genetic risk factors for AA amyloidosis in Algerian patients with familial Mediterranean fever
• Recurrent Bouts of Fever and Transient Hydrosalpinx Manifested in a Female Carrying MEFV G304R Gene Variant: A Case Report
• Relationship between sacroiliitis and inflammatory markers in familial Mediterranean fever
• Reliability of a generative artificial intelligence tool for pediatric familial Mediterranean fever: insights from a multicentre expert survey
• Repeated attacks of hereditary angioedema in pediatric female
• Risk for cancer development in familial Mediterranean fever and associated predisposing factors: an ambidirectional cohort study from the international AIDA Network registries
• Role of Colchicine in Cardiovascular Disorders
• Role of serum calprotectin in identifying familial Mediterranean fever attacks
• Sacroiliitis in familial Mediterranean fever: A rare joint involvement of the disease
• Serum endocan, asymmetric dimethylarginine and lipid profile in children with familial Mediterranean fever
• Severity scores, damage indices and the concept of the colchicine-resistant patient in familial Mediterranean fever
• Solving a diagnostic dilemma in a patient with periodic fever-When the pieces of the puzzle finally fit
• Study on crack resistance of self-healing microcapsules in asphalt pavement by multi-scale method
• Tertiary adrenal insufficiency in a patient with familial Mediterranean fever: Association or coincidence?
• The assessment of fatigue and sleep quality among children and adolescents with familial Mediterranean fever: A case-control and correlation study
• The effectiveness of anti-interleukin-1 therapy on subclinical inflammation parameters during the attack-free period in familial Mediterranean fever patients: A case-control study
• The evaluation of depression and anxiety levels of mothers of patients with periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome and familial Mediterranean fever
• The Impact of Different MEFV Genotypes on Clinical Phenotype of Patients with Familial Mediterranean Fever: Special Emphasis on Joint Involvement
• The increased chromosomal DNA damage in patients with Familial Mediterranean Fever
• The most frequent febrile syndromes and autoinflammatory diseases in adulthood
• The past 25 years in paediatric rheumatology: insights from monogenic diseases
• The Quality of Life in Patients with Familial Mediterranean Fever and Their Parents Perception
• The role of colchicine in the management of COVID-19: a Meta-analysis
• The Role of Tenascin-C in the Physiopathology of Familial Mediterranean Fever
• The roles of SFKs in the regulation of proinflammatory cytokines and NLRP3 in familial mediterranean fever patients
• The significance of carrying MEFV variants in symptomatic and asymptomatic individuals
• The usefulness and reliability of English-language YouTube videos as a source of knowledge for patients with familial Mediterranean fever
• TNFRSF11A variants contribute to systemic autoinflammatory diseases: A case series of 12 patients
• Tocilizumab-Induced Sweet Syndrome in a Familial Mediterranean Fever Patient: A Case Report
• Update on ocular manifestations of the main monogenic and polygenic autoinflammatory diseases
• Updates on the role of epigenetics in familial mediterranean fever (FMF)